←Back to Expert Scholars
Translational Medicine / 转化医学Checkpoint Combinations, Thoracic Immunotherapy
Rachel Sanborn
MD
🏢Providence Cancer Institute🌐USA
Medical Director, Thoracic Oncology Program
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Rachel Sanborn leads thoracic oncology at Providence Cancer Institute and has conducted pivotal trials of checkpoint combinations in lung cancer. She has contributed to studies of CTLA-4 plus PD-1 combinations and novel immunotherapy agents in NSCLC and SCLC. Her work shapes thoracic immunotherapy practice.
Share:
🧪Research Fields 研究领域
thoracic immunotherapy
lung cancer checkpoint combinations
CTLA-4 combinations
SCLC immunotherapy
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Rachel Sanborn 的研究动态
Follow Rachel Sanborn's research updates
留下邮箱，当我们发布与 Rachel Sanborn（Providence Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment